Molecular Diagnostics

Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy

Abstract

Background

This study aimed to evaluate the prognostic value of pre-treatment NLR in patients with oropharyngeal cancer.

Methods

Patients who completed definitive radiotherapy (RT) for oropharyngeal cancer and had blood counts taken pre-RT from 2002 to 2013 were included. NLR was calculated as total neutrophil/lymphocytes. Survival rates were estimated using the Kaplan–Meier method. Univariable and multivariable analyses were conducted with linear and Cox regression methods. NLR was analysed posteriori and dichotomised on the discovered median.

Results

Eight hundred and forty-eight patients were analysed. The median pre-RT NLR was 3. Patients with NLR of <3 had improved overall survival (OS) than those with NLR ≥ 3 (5-year OS 85 vs 74%, p < 0.0001). OS differences remained significant when stratified according to HPV status (HPV-positive p = 0.011; HPV-negative p = 0.003). Freedom from any recurrence (FFR), locoregional control (LRC) and freedom of distant recurrence (FDR) were better in those with NLR < 3. The negative impact of elevated pre-RT NLR on OS (HR = 1.64, p = 0.001), FFR (HR = 1.6, p = 0.006) and LRC (HR = 1.8, p = 0.005) remained significant on multivariable analysis.

Conclusions

Pre-RT NLR is an independent prognostic factor in patients with oropharyngeal cancer regardless of HPV status. Patients with lower NLR had more favourable OS and disease control.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Chaturvedi, A. K., Anderson, W. F., Lortet-Tieulent, J., Curado, M. P., Ferlay, J., Franceschi, S. et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J. Clin. Oncol. 31, 4550–4559 (2013).

    Article  Google Scholar 

  2. 2.

    Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).

    CAS  Article  Google Scholar 

  3. 3.

    Conteduca, V., Crabb, S. J., Jones, R. J., Caffo, O., Elliott, T., Scarpi, E. et al. Persistent neutrophil to lymphocyte ratio >3 during treatment with enzalutamide and clinical outcome in patients with castration-resistant prostate cancer. PLoS ONE 11, e0158952 (2016).

    Article  Google Scholar 

  4. 4.

    Kim, T. W., Lee, J. H., Shim, K. H., Choo, S. H., Choi, J. B., Ahn, H. S. et al. Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. Investig. Clin. Urol. 60, 14–20 (2019).

    Article  Google Scholar 

  5. 5.

    Choi, J. H., Suh, Y. S., Choi, Y., Han, J., Kim, T. H., Park, S. H. et al. Comprehensive analysis of the neutrophil-to-lymphocyte ratio for preoperative prognostic prediction nomogram in gastric cancer. World J. Surg. 42, 2530–2541 (2018).

    Article  Google Scholar 

  6. 6.

    Mason, M., Maurice, C., McNamara, M. G., Tieu, M. T., Lwin, Z., Millar, B. A. et al. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival. J. Neurooncol. 132, 463–471 (2017).

    Article  Google Scholar 

  7. 7.

    Kuo, C., Hsueh, W. T., Wu, Y. H., Yang, M. W., Cheng, Y. J., Pao, T. H. et al. The role of pretreatment serum neutrophil-to-lymphocyte ratio in hypopharyngeal cancer treated with definitive chemoradiotherapy: a pilot study. Sci. Rep. 9, 1618 (2019).

    Article  Google Scholar 

  8. 8.

    Templeton, A. J., McNamara, M. G., Seruga, B., Vera-Badillo, F. E., Aneja, P., Ocana, A. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl Cancer Inst. 106, dju124 (2014).

    Article  Google Scholar 

  9. 9.

    Takenaka, Y., Oya, R., Kitamiura, T., Ashida, N., Shimizu, K., Takemura, K. et al. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: a meta-analysis. Head Neck 40, 647–655 (2018).

    Article  Google Scholar 

  10. 10.

    Charles, K. A., Harris, B. D., Haddad, C. R., Clarke, S. J., Guminski, A., Stevens, M. et al. Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients. BMC Cancer 16, 124 (2016).

    Article  Google Scholar 

  11. 11.

    Cho, Y. Kim, J. W., Yoon, H. I., Lee, C. G., Keum, K. C. & Lee, I. J. The prognostic significance of neutrophil-to-lymphocyte ratio in head and neck cancer patients treated with radiotherapy. J. Clin. Med. https://doi.org/10.3390/jcm7120512 (2018).

  12. 12.

    So, Y. K., Lee, G., Oh, D., Byeon, S., Park, W. & Chung, M. K. Prognostic role of neutrophil-to-lymphocyte ratio in patients with human papillomavirus-positive oropharyngeal cancer. Otolaryngol. Head Neck Surg. 159, 303–309 (2018).

    Article  Google Scholar 

  13. 13.

    Chandrasekara, S., Davis, S., Thomson, P. & Haydon, A. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy. Asia Pac. J. Clin. Oncol. 14, e442–e447 (2018).

    Article  Google Scholar 

  14. 14.

    Bojaxhiu, B., Templeton, A. J., Elicin, O., Shelan, M., Zaugg, K., Walser, M. et al. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Radiat. Oncol. 13, 216 (2018).

    CAS  Article  Google Scholar 

  15. 15.

    Kim, D. Y., Kim, I. S., Park, S. G., Kim, H., Choi, Y. J. & Seol, Y. M. Prognostic value of posttreatment neutrophil-lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy. Auris Nasus Larynx 44, 199–204 (2017).

    Article  Google Scholar 

  16. 16.

    Cho, J. K., Kim, M. W., Choi, I. S., Moon, U. Y., Kim, M. J., Sohn, I. et al. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study. BMC Cancer 18, 969 (2018).

    CAS  Article  Google Scholar 

  17. 17.

    Lin, A. J., Gang, M., Rao, Y. J., Campian, J., Daly, M., Gay, H. et al. Association of posttreatment lymphopenia and elevated neutrophil-to-lymphocyte ratio with poor clinical outcomes in patients with human papillomavirus-negative oropharyngeal cancers. JAMA Otolaryngol. Head Neck Surg. 145, 413–421 (2019).

    Article  Google Scholar 

  18. 18.

    Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

    CAS  Article  Google Scholar 

  19. 19.

    Goldenberg, D., Begum, S., Westra, W. H., Khan, Z., Sciubba, J., Pai, S. I. et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 30, 898–903 (2008).

    Article  Google Scholar 

  20. 20.

    Tang, C., Fuller, C. D., Garden, A. S., Awan, M. J., Colen, R. R., Morrison, W. H. et al. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. Oral. Oncol. 51, 195–201 (2015).

    Article  Google Scholar 

  21. 21.

    Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

S.P.N.: conceptualisation, data curation, formal analysis, investigation, methodology, project administration, visualisation, writing—original draft, and writing—review and editing. H.B.: data curation, investigation, visualisation, and writing—review and editing. A.J.: data curation and writing—review and editing. E.M.S., F.M.J., G.B.G., R.F., J.P., D.I.R., S.J.F. and C.D.F.: resources, methodology, and writing—review and editing. B.E.: methodology and writing—review and editing. A.S.G.: supervision, project administration, resources, writing—original draft, and writing—review and editing.

Corresponding authors

Correspondence to Sweet Ping Ng or Adam S. Garden.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center. Informed consent was waived. This study was performed in accordance with the Declaration of Helsinki.

Consent to publish

Not applicable.

Data availability

Data will be available on request.

Competing interests

The authors declare no competing interests.

Funding information

S.P.N. is funded by the Australian Postgraduate Award, the Royal Australian and New Zealand College of Radiologists (RANZCR) Research Grant and the Radiological Society of North America (RSNA) Fellow Grant. C.D.F. was supported by Andrew Sabin Family Fellowship. C.D.F. received funding support from the National Institutes of Health (NIH)/National Institute for Dental and Craniofacial Research (NIDCR) (1R01DE025248-01/R56DE025248-01). C.D.F. was previously funded via the National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF DMS-1557679) and is currently supported by the NIH National Cancer Institute (NCI)/Big Data to Knowledge (BD2K) Program (1R01CA214825-01), the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Career Development Award (P50CA097007-10); the NCI Paul Calabresi Clinical Oncology Program Award (K12 CA088084-06); a General Electric Healthcare/MD Anderson Center for Advanced Biomedical Imaging In-Kind Award; an Elekta AB/MD Anderson Department of Radiation Oncology Seed Grant; the Center for Radiation Oncology Research (CROR) at MD Anderson Cancer Center Seed Grant and the MD Anderson Institutional Research Grant (IRG) Program. C.D.F. has received speaker travel funding from Elekta AB. This study was supported in part by the NIH/NCI Cancer Center Support (Core) Grant CA016672 to The University of Texas MD Anderson Cancer Center (P30 CA016672). F.M.J. has received research funding from PIQUR Therapeutics and Trovagene. E.M.S. has a research award from Roche Diagnostics supporting HPV testing of oral rinse and mucosal swab samples on the clinical trial for HPV-related cancers screening in men (HOUSTON study).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ng, S.P., Bahig, H., Jethanandani, A. et al. Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy. Br J Cancer (2020). https://doi.org/10.1038/s41416-020-01106-x

Download citation

Search